Softwr

Healthcare · head to head

Oracle Clinical One vs Techcyte

Oracle Clinical One logo

Oracle Clinical One

Healthcare

Unified clinical trial data collection and randomisation on one Oracle Life Sciences platform

From
On request
Rated
-
Techcyte logo

Techcyte

Healthcare

AI digital pathology across clinical, veterinary and environmental laboratory disciplines

From
On request
Rated
-

The short version

  • Each has a real cost: Oracle Clinical One nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.; Techcyte regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • They diverge on capability: Oracle Clinical One covers Unified platform, Techcyte covers Fusion Parasitology Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Oracle Clinical One and Techcyte actually diverge.

Attributes where Oracle Clinical One and Techcyte differ
AttributeOracle Clinical OneTechcyte
PlatformsWeb, iOS, AndroidWeb

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Oracle Clinical One

  • Unified platform
  • Data collection
  • Randomisation and supplies
  • No-code study build
  • Regulatory compliance
  • Mid-study changes
  • Integrations
  • Cloud delivery

Only in Techcyte

  • Fusion Parasitology Suite
  • Cervical cytology
  • Haematology
  • Urinalysis
  • Bacteriology and mycology
  • Vetcyte
  • Scanner agnostic ingestion
  • Remote review

What people use each for

The jobs each tool is most often brought in to do.

Oracle Clinical One

  • A sponsor running a complex Phase III where randomisation errors between separate EDC and RTSM vendors have already cost timenot Techcyte
  • A pharmaceutical company already on Oracle Clinical or InForm that needs a supported migration path off end-of-life systemsnot Techcyte
  • A trial with adaptive randomisation and drug supply forecasting that would otherwise need custom programming per amendmentnot Techcyte
  • A CRO standardising study build across many sponsor programmes on one validated platformnot Techcyte

Techcyte

  • A clinical laboratory that cannot recruit technologists for high volume manual parasitology screening and needs AI pre screening with human releasenot Oracle Clinical One
  • A veterinary reference laboratory processing large volumes of faecal and blood smears that wants Vetcyte to triage the normal casesnot Oracle Clinical One
  • A European laboratory that can deploy the CE marked products clinically, which is where Techcyte regulatory position is strongestnot Oracle Clinical One
  • An environmental testing laboratory needing consistent microscopy classification across analysts and sitesnot Oracle Clinical One

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Oracle Clinical One

  • Nothing about the commercial terms is published, so cost, implementation length and validation scope all emerge inside an enterprise sales process, and comparison shopping requires running parallel procurements.
  • Placing data collection and randomisation with a single vendor concentrates risk: an outage or a defect affects both of the systems your sites cannot work without.
  • Mid-study amendments are routine in trials but flow through the vendor change control process, and change orders are where the real cost of an Oracle trial platform accumulates after signature.
  • Implementation and study build require specialist staff or Oracle services, so the practical time from contract to first patient in is measured in months, not weeks.
  • It is aimed squarely at sponsors and CROs with established trial operations, and a small biotech running its first study will find the platform, the contracting and the validation burden heavier than its team can absorb.

Techcyte

  • Regulatory status runs the opposite way to what most buyers assume: the products are CE marked and clinically deployed in Europe while several United States offerings including Fusion Parasitology are labelled research use only and not for diagnostic use, so an American laboratory must verify each module individually.
  • Slide scanning for parasitology, haematology and cytology needs multi plane imaging that a histology scanner may not produce, so a laboratory that already owns a scanner often has to buy new hardware, which becomes the biggest line in the project.
  • Each discipline is licensed separately, so a laboratory wanting parasitology, urinalysis and haematology assembles three modules and three validation studies rather than buying one platform.
  • AI pre screening does not remove the need for a qualified reviewer to release results, so the staffing saving is in review time per slide, not in headcount, and business cases that assume otherwise do not hold.
  • Techcyte covers a very wide set of disciplines, which means depth varies between them, and the maturity of a newer module is not the maturity of the parasitology or cytology products that made the company its name.

Pricing, plan by plan

Oracle Clinical One

On request
  • Clinical One Data Collection$undefined/year
    • Pricing only through Oracle sales
    • Priced against study count, sites and subjects
    • Study build and configuration services quoted separately
  • Clinical One Randomization and Supplies Management$undefined/year
    • Quoted alongside or independently of Data Collection
    • Randomisation strategy configuration included in the service
    • Supply forecasting and kit management

Techcyte

On request
  • Techcyte$undefined/year
    • Priced per slide or per annual specimen volume by discipline
    • Each discipline module licensed separately
    • Slide scanning hardware bought separately, not included

Which should you pick?

Choose Oracle Clinical One if

  • You need unified platform.
  • You work on Web, iOS, Android.
  • You also want data collection.

Choose Techcyte if

  • You need fusion parasitology suite.
  • You also want cervical cytology.

Questions people ask

Is Oracle Clinical One or Techcyte better?
Neither clearly leads. Oracle Clinical One starts at On request and Techcyte at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Oracle Clinical One or Techcyte?
Oracle Clinical One starts at On request and Techcyte at On request.
Does Oracle Clinical One or Techcyte run on more platforms?
Oracle Clinical One runs on Web, iOS, Android. Techcyte runs on Web.
What is Oracle Clinical One best used for?
Oracle Clinical One is most often used for a sponsor running a complex phase iii where randomisation errors between separate edc and rtsm vendors have already cost time, a pharmaceutical company already on oracle clinical or inform that needs a supported migration path off end-of-life systems, a trial with adaptive randomisation and drug supply forecasting that would otherwise need custom programming per amendment, a cro standardising study build across many sponsor programmes on one validated platform. Of those, a sponsor running a complex phase iii where randomisation errors between separate edc and rtsm vendors have already cost time and a pharmaceutical company already on oracle clinical or inform that needs a supported migration path off end-of-life systems are not what Techcyte is typically brought in for.
What can Oracle Clinical One do that Techcyte cannot?
Oracle Clinical One covers Unified platform, Data collection, Randomisation and supplies, No-code study build. Techcyte covers Fusion Parasitology Suite, Cervical cytology, Haematology, Urinalysis.

Answered from the vendors’ own pages

Oracle Clinical One: What replaced Oracle Clinical and InForm?

Clinical One is the current Oracle Life Sciences platform, and sponsors on the older Oracle Clinical and InForm products are the primary migration audience.

Techcyte: Is Techcyte FDA cleared?

Not uniformly. Several United States offerings, including the Fusion Parasitology Suite, are labelled research use only and not for diagnostic use in the United States. Check the regulatory status of each specific module for your country before purchase.

Oracle Clinical One: Can I buy randomisation without data collection?

Yes. Clinical One Randomization and Supplies Management can integrate with a third-party EDC if you want to keep an incumbent capture system.

Techcyte: Can we use it clinically in Europe?

Techcyte solutions are CE marked and clinically deployed across Europe, which is where its regulatory position is strongest. Confirm the current certificate for the specific module.

Oracle Clinical One: Is pricing published?

No. Every element, including licence, study build, implementation and validation, comes through Oracle sales.

Techcyte: Does it eliminate the need for a technologist?

No. AI pre screens and prioritises, but a qualified reviewer still releases results. The saving is in review time per slide.

Oracle Clinical One: Is it validated for regulated trials?

It is delivered as a validated cloud service with GxP documentation and Part 11 aligned audit trails, but sponsor-level validation of your own configuration remains your responsibility.

Techcyte: Do we need a specific scanner?

Techcyte works with several scanner vendors, but disciplines such as parasitology and haematology need multi plane imaging that many histology scanners cannot produce, so confirm hardware compatibility early.

Share

Related pages

Other head to heads